Psychometric Evaluation of the Serbian Version of the Southampton Dupuytren's Scoring Scheme in Patients with Dupuytren's Contracture

对塞尔维亚语版南安普顿杜普伊特伦挛缩症评分方案在杜普伊特伦挛缩症患者中的心理测量学评价

阅读:1

Abstract

Background/Objectives: Dupuytren's contracture is a chronic fibroproliferative disorder of the palmar fascia that leads to progressive flexion deformities and functional impairment. The Southampton Dupuytren's Scoring Scheme (SDSS) is a disease-specific patient-reported outcome measure designed to quantify disability in this condition. This study aimed to translate, culturally adapt, and evaluate the psychometric properties of the Serbian version of the SDSS. Methods: A cross-sectional study was conducted at the Institute for Orthopedic Surgery "Banjica", Belgrade, from January 2024 to March 2025. Sixty-eight patients with Dupuytren's contracture completed the Serbian SDSS, the Disabilities of the Arm, Shoulder and Hand (DASH) questionnaire, the 12-Item Short Form Health Survey (SF-12), and a Visual Analogue Scale (VAS) for pain. Translation followed standardized forward-backward procedures. Internal consistency was assessed with Cronbach's alpha, construct validity with confirmatory factor analysis (CFA), and convergent validity with Pearson's correlation coefficients. Results: The Serbian SDSS demonstrated excellent internal consistency (Cronbach's α = 0.914). CFA supported a unidimensional five-item structure with strong factor loadings (0.76-0.93) and acceptable fit indices (χ(2) = 10.094, df = 5, p = 0.073; IFI = 0.979; CFI = 0.978; TLI = 0.956). Convergent validity was confirmed by strong correlations with DASH (r = 0.779) and VAS (r = 0.702) and a strong negative correlation with SF-12 PCS (r = -0.802). Conclusions: The Serbian SDSS is a valid and reliable instrument for assessing functional disability in patients with Dupuytren's contracture and offers a robust, patient-centered measure for clinical and research use.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。